315 related articles for article (PubMed ID: 16902972)
21. Organ specific Gst-pi expression of the metastatic androgen independent prostate cancer cells in nude mice.
Naiki T; Asamoto M; Toyoda-Hokaiwado N; Naiki-Ito A; Tozawa K; Kohri K; Takahashi S; Shirai T
Prostate; 2012 Apr; 72(5):533-41. PubMed ID: 21748757
[TBL] [Abstract][Full Text] [Related]
22. Characterization of E-cadherin-dependent and -independent events in a new model of c-Fos-mediated epithelial-mesenchymal transition.
Mejlvang J; Kriajevska M; Berditchevski F; Bronstein I; Lukanidin EM; Pringle JH; Mellon JK; Tulchinsky EM
Exp Cell Res; 2007 Jan; 313(2):380-93. PubMed ID: 17141758
[TBL] [Abstract][Full Text] [Related]
23. A human three-dimensional cell line model allows the study of dynamic and reversible epithelial-mesenchymal and mesenchymal-epithelial transition that underpins colorectal carcinogenesis.
Vincan E; Brabletz T; Faux MC; Ramsay RG
Cells Tissues Organs; 2007; 185(1-3):20-8. PubMed ID: 17587804
[TBL] [Abstract][Full Text] [Related]
24. miR-205 Exerts tumor-suppressive functions in human prostate through down-regulation of protein kinase Cepsilon.
Gandellini P; Folini M; Longoni N; Pennati M; Binda M; Colecchia M; Salvioni R; Supino R; Moretti R; Limonta P; Valdagni R; Daidone MG; Zaffaroni N
Cancer Res; 2009 Mar; 69(6):2287-95. PubMed ID: 19244118
[TBL] [Abstract][Full Text] [Related]
25. Constitutive expression of RbAp46 induces epithelial-mesenchymal transition in mammary epithelial cells.
Li GC; Wang ZY
Anticancer Res; 2006; 26(5A):3555-60. PubMed ID: 17094482
[TBL] [Abstract][Full Text] [Related]
26. In vivo models of human prostate cancer bone metastasis.
Brown JM
Methods Mol Med; 2003; 81():149-62. PubMed ID: 12725119
[No Abstract] [Full Text] [Related]
27. Evidence of epithelial to mesenchymal transition associated with increased tumorigenic potential in an immortalized normal prostate epithelial cell line.
Marian CO; Yang L; Zou YS; Gore C; Pong RC; Shay JW; Kabbani W; Hsieh JT; Raj GV
Prostate; 2011 May; 71(6):626-36. PubMed ID: 20945502
[TBL] [Abstract][Full Text] [Related]
28. Epithelial plasticity, cancer stem cells and bone metastasis formation.
van der Pluijm G
Bone; 2011 Jan; 48(1):37-43. PubMed ID: 20670698
[TBL] [Abstract][Full Text] [Related]
29. Thyroid transcription factor-1 inhibits transforming growth factor-beta-mediated epithelial-to-mesenchymal transition in lung adenocarcinoma cells.
Saito RA; Watabe T; Horiguchi K; Kohyama T; Saitoh M; Nagase T; Miyazono K
Cancer Res; 2009 Apr; 69(7):2783-91. PubMed ID: 19293183
[TBL] [Abstract][Full Text] [Related]
30. [Expression of Smad4 in prostate cancer LNCaP and ARCaP cell lines with different metastatic potentials and its significance].
Wu KJ; Zhang D; Zhu GF; Cheng HP; Zeng J; Zhang LL; Wang XY; He DL
Zhonghua Nan Ke Xue; 2009 Jan; 15(1):41-4. PubMed ID: 19288748
[TBL] [Abstract][Full Text] [Related]
31. Malignant transformation in a nontumorigenic human prostatic epithelial cell line.
Hayward SW; Wang Y; Cao M; Hom YK; Zhang B; Grossfeld GD; Sudilovsky D; Cunha GR
Cancer Res; 2001 Nov; 61(22):8135-42. PubMed ID: 11719442
[TBL] [Abstract][Full Text] [Related]
32. Over-expression of EphB3 enhances cell-cell contacts and suppresses tumor growth in HT-29 human colon cancer cells.
Chiu ST; Chang KJ; Ting CH; Shen HC; Li H; Hsieh FJ
Carcinogenesis; 2009 Sep; 30(9):1475-86. PubMed ID: 19483190
[TBL] [Abstract][Full Text] [Related]
33. Mechanisms of motility in metastasizing cells.
Yilmaz M; Christofori G
Mol Cancer Res; 2010 May; 8(5):629-42. PubMed ID: 20460404
[TBL] [Abstract][Full Text] [Related]
34. Found in translation: A new player in EMT.
Mackenzie NC; Raz E
Dev Cell; 2006 Oct; 11(4):434-6. PubMed ID: 17011482
[TBL] [Abstract][Full Text] [Related]
35. Epithelial-to-mesenchymal transition and resistance to ingenol 3-angelate, a novel protein kinase C modulator, in colon cancer cells.
Ghoul A; Serova M; Astorgues-Xerri L; Bieche I; Bousquet G; Varna M; Vidaud M; Phillips E; Weill S; Benhadji KA; Lokiec F; Cvitkovic E; Faivre S; Raymond E
Cancer Res; 2009 May; 69(10):4260-9. PubMed ID: 19417139
[TBL] [Abstract][Full Text] [Related]
36. Epithelial-mesenchymal transition in prostate cancer and the potential role of kallikrein serine proteases.
Lawrence MG; Veveris-Lowe TL; Whitbread AK; Nicol DL; Clements JA
Cells Tissues Organs; 2007; 185(1-3):111-5. PubMed ID: 17587816
[TBL] [Abstract][Full Text] [Related]
37. Tissue-specific consequences of cyclin D1 overexpression in prostate cancer progression.
He Y; Franco OE; Jiang M; Williams K; Love HD; Coleman IM; Nelson PS; Hayward SW
Cancer Res; 2007 Sep; 67(17):8188-97. PubMed ID: 17804732
[TBL] [Abstract][Full Text] [Related]
38. Epidermal growth factor-induced epithelial-mesenchymal transition in human esophageal carcinoma cells--a model for the study of metastasis.
Cai Z; Wang Q; Zhou Y; Zheng L; Chiu JF; He QY
Cancer Lett; 2010 Oct; 296(1):88-95. PubMed ID: 20413216
[TBL] [Abstract][Full Text] [Related]
39. Maspin reduces prostate cancer metastasis to bone.
Hall DC; Johnson-Pais TL; Grubbs B; Bernal R; Leach RJ; Padalecki SS
Urol Oncol; 2008; 26(6):652-8. PubMed ID: 18367129
[TBL] [Abstract][Full Text] [Related]
40. Epithelial-mesenchymal and mesenchymal-epithelial transitions during cancer progression.
Spaderna S; Schmalhofer O; Hlubek F; Jung A; Kirchner T; Brabletz T
Verh Dtsch Ges Pathol; 2007; 91():21-8. PubMed ID: 18314592
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]